Blood levels of glial fibrillary acidic protein for predicting clinical progression to Alzheimer’s disease in adults without dementia: a systematic review and meta-analysis protocol
Takashi Nihashi(National Center for Geriatrics and Gerontology), Teruhiko Terasawa(Tufts University), Yasuyuki Kimura(National Center for Geriatrics and Gerontology), Akinori Nakamura(National Center for Geriatrics and Gerontology), Kengo Ito(National Center for Geriatrics and Gerontology), Takashi Kato(National Center for Geriatrics and Gerontology), Keita Sakurai(National Center for Geriatrics and Gerontology)
Cited by 5
Related Papers
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment
|PLoS ONE|2013|388
Somatosensory Homunculus as Drawn by MEG
|NeuroImage|1998|342